Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 369

Similar articles for PubMed (Select 9723629)

1.

Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation.

Pengo V, Zasso A, Barbero F, Banzato A, Nante G, Parissenti L, John N, Noventa F, Dalla Volta S.

Am J Cardiol. 1998 Aug 15;82(4):433-7.

PMID:
9723629
2.

Safety of the direct-acting anticoagulants in patients with atrial fibrillation: a meta-analysis.

Rong F, Jia B, Huang P, Lynn HS, Zhang W.

Thromb Res. 2015 Jun;135(6):1117-23. doi: 10.1016/j.thromres.2015.04.004. Epub 2015 Apr 11.

PMID:
25891842
3.
4.

Alternative calculations of individual patient time in therapeutic range while taking warfarin: results from the ROCKET AF trial.

Singer DE, Hellkamp AS, Yuan Z, Lokhnygina Y, Patel MR, Piccini JP, Hankey GJ, Breithardt G, Halperin JL, Becker RC, Hacke W, Nessel CC, Mahaffey KW, Fox KA, Califf RM; ROCKET AF Investigators.

J Am Heart Assoc. 2015 Mar 3;4(3):e001349. doi: 10.1161/JAHA.114.001349.

5.

Safety and efficacy of well managed warfarin. A report from the Swedish quality register Auricula.

Sjögren V, Grzymala-Lubanski B, Renlund H, Friberg L, Lip GY, Svensson PJ, Själander A.

Thromb Haemost. 2015 May 26;113(6):1370-7. doi: 10.1160/TH14-10-0859. Epub 2015 Feb 26.

PMID:
25716771
6.

Warfarin Treatment and Outcomes of Patients With Atrial Fibrillation in Rural and Urban Settings.

Avgil Tsadok M, Jackevicius CA, Essebag V, Eisenberg MJ, Rahme E, Pilote L.

J Rural Health. 2015 Jul;31(3):310-315. doi: 10.1111/jrh.12110. Epub 2015 Feb 25.

PMID:
25716686
7.

Anemia predicts thromboembolic events, bleeding complications and mortality in patients with atrial fibrillation: insights from the RE-LY trial.

Westenbrink BD, Alings M, Connolly SJ, Eikelboom J, Ezekowitz MD, Oldgren J, Yang S, Pongue J, Yusuf S, Wallentin L, van Gilst WH.

J Thromb Haemost. 2015 May;13(5):699-707. doi: 10.1111/jth.12874. Epub 2015 Mar 30.

PMID:
25683276
8.

Economic evaluation of pharmacogenomic-guided warfarin treatment for elderly Croatian atrial fibrillation patients with ischemic stroke.

Mitropoulou C, Fragoulakis V, Bozina N, Vozikis A, Supe S, Bozina T, Poljakovic Z, van Schaik RH, Patrinos GP.

Pharmacogenomics. 2015 Jan;16(2):137-48. doi: 10.2217/pgs.14.167.

PMID:
25616100
9.

Genotype-Guided Dosing of Coumarin Anticoagulants: A Meta-analysis of Randomized Controlled Trials.

Tang T, Liu J, Zuo K, Cheng J, Chen L, Lu C, Han S, Xu J, Jia Z, Ye M, Pei E, Zhang X, Li M.

J Cardiovasc Pharmacol Ther. 2015 Jul;20(4):387-94. doi: 10.1177/1074248414565666. Epub 2015 Jan 8.

PMID:
25575537
10.

Evaluating time in therapeutic range for hemodialysis patients taking warfarin.

Quinn LM, Richardson R, Cameron KJ, Battistella M.

Clin Nephrol. 2015 Feb;83(2):80-5. doi: 10.5414/CN108400.

PMID:
25500296
11.

Target intensity of anticoagulation with warfarin in Japanese patients with valvular atrial fibrillation – subanalysis of the J-RHYTHM Registry.

Kodani E, Atarashi H, Inoue H, Okumura K, Yamashita T; J-RHYTHM Registry Investigators.

Circ J. 2015;79(2):325-30. doi: 10.1253/circj.CJ-14-1057. Epub 2014 Dec 10.

12.

Combined low-dose aspirin and warfarin anticoagulant therapy of postoperative atrial fibrillation following mechanical heart valve replacement.

Wang JT, Dong MF, Song GM, Ma ZS, Ma SJ.

J Huazhong Univ Sci Technolog Med Sci. 2014 Dec;34(6):902-6. doi: 10.1007/s11596-014-1371-4. Epub 2014 Dec 6.

PMID:
25480588
13.

[Indication of treatment with Warfarin should be stated explicitly.]

Vestergaard T, Hjort J, Madsen HB, Povlsen JA, Løfgren B.

Ugeskr Laeger. 2014 Nov 17;176(47). pii: V07140399. Danish.

PMID:
25430539
14.

Out-of-range INR values and outcomes among new warfarin patients with non-valvular atrial fibrillation.

Nelson WW, Wang L, Baser O, Damaraju CV, Schein JR.

Int J Clin Pharm. 2015 Feb;37(1):53-9. doi: 10.1007/s11096-014-0038-3. Epub 2014 Nov 27.

15.

Intracranial hemorrhage and subsequent ischemic stroke in patients with atrial fibrillation: a nationwide cohort study.

Brønnum Nielsen P, Larsen TB, Gorst-Rasmussen A, Skjøth F, Rasmussen LH, Lip GY.

Chest. 2015 Jun;147(6):1651-8. doi: 10.1378/chest.14-2099.

PMID:
25412369
16.

Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial.

Reddy VY, Sievert H, Halperin J, Doshi SK, Buchbinder M, Neuzil P, Huber K, Whisenant B, Kar S, Swarup V, Gordon N, Holmes D; PROTECT AF Steering Committee and Investigators.

JAMA. 2014 Nov 19;312(19):1988-98. doi: 10.1001/jama.2014.15192. Erratum in: JAMA. 2015 Mar 10;313(10):1061.

PMID:
25399274
17.

Warfarin use, mortality, bleeding and stroke in haemodialysis patients with atrial fibrillation.

Genovesi S, Rossi E, Gallieni M, Stella A, Badiali F, Conte F, Pasquali S, Bertoli S, Ondei P, Bonforte G, Pozzi C, Rebora P, Valsecchi MG, Santoro A.

Nephrol Dial Transplant. 2015 Mar;30(3):491-8. doi: 10.1093/ndt/gfu334. Epub 2014 Oct 28.

PMID:
25352571
18.

Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trial.

Flaker G, Lopes RD, Hylek E, Wojdyla DM, Thomas L, Al-Khatib SM, Sullivan RM, Hohnloser SH, Garcia D, Hanna M, Amerena J, Harjola VP, Dorian P, Avezum A, Keltai M, Wallentin L, Granger CB; ARISTOTLE Committees and Investigators.

J Am Coll Cardiol. 2014 Oct 14;64(15):1541-50. doi: 10.1016/j.jacc.2014.07.967.

PMID:
25301455
19.

Small therapeutic window of warfarin in Japanese population.

Watanabe E.

J Cardiol. 2015 Mar;65(3):171-2. doi: 10.1016/j.jjcc.2014.09.003. Epub 2014 Oct 3. No abstract available.

20.

Computerized clinical decision support improves warfarin management and decreases recurrent venous thromboembolism.

Woller SC, Stevens SM, Towner S, Olson J, Christensen P, Hamilton S, Newman L, Mott L, Hu P, Brunisholz KD, Long Y, Lloyd J, Evans RS, Cannon W, Elliott CG.

Clin Appl Thromb Hemost. 2015 Apr;21(3):197-203. doi: 10.1177/1076029614550818. Epub 2014 Sep 16.

PMID:
25228672
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk